Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension

Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension

Abstract The deficiency of antigen‐specific T cells and the induction of various treatment‐induced immunosuppressions still limits the clinical benefit of cancer immunotherapy. Although the chemo‐immunotherapy adjuvanted with Toll‐like receptor 7/8 agonist (TLR 7/8a) induces immunogenic cell death (...

Full description

Bibliographic Details
Main Authors: Seung Mo Jin, Sang Nam Lee, Jung Eun Kim, Yeon Jeong Yoo, Chanyoung Song, Hong Sik Shin, Hathaichanok Phuengkham, Chang Hoon Lee, Soong Ho Um, Yong Taik Lim
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Advanced Science
Subjects:
adjuvants
drug delivery
immunosuppression
immunotherapy
tumor microenvironment
Online Access:https://doi.org/10.1002/advs.202102043

Internet

https://doi.org/10.1002/advs.202102043

Similar Items